跳至主要内容
临床试验/NCT01989832
NCT01989832已完成不适用

Pharmaco-economical Study in Kidney Transplantation

University Hospital, Limoges0 个研究点目标入组 570 人开始时间: 2013年2月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
570
主要终点
Number of Death

研究概览

简要总结

The prevalence of renal acute rejection in transplantation is reduced thanks to the optimized use of immunosuppressive drugs. However, graft survival at ten years has not improved since then; this may be explained in part by the toxicity of these drugs, viral infections, and other comorbidities (diabetes, cardiovascular diseases ...).

According to transplant center, strategies for the combination of immunosuppressive drugs are different, and probably involve a difference in the global cost of patient management. There is no recommendation in France to establish similar practices.

EPHEGREN is an observational, prospective, multicentric, pharmacoeconomic study for the renal transplant patients.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients in the first month of renal graft, or patients already included in an other epidemiological French study (EPIGREN) in the 0-6 month period
  • Men of women aged more than 18 years
  • Patients able to exercise in writing their informed and free consent to participate to the biological collection
  • Patients not opposing to collect their medical data
  • Patients registered with a social security system
  • Patients able to complete the questionnaires

排除标准

  • Patients aged less than 18 years and patients under guardianship
  • Patients with a follow-up at another center other than those part of the study

结局指标

主要结局

Number of Death

时间窗: 4 years

次要结局

  • to examine nature, dose and exposure in immunosuppresseurs.(4 years)

研究者

发起方
University Hospital, Limoges
申办方类型
Other
责任方
Sponsor

相似试验